| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 1,103.43 | 1,066.04 | 1,157.01 | 961.39 |
| Sale of Products | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Services | 1,103.43 | 1,066.04 | 1,157.00 | 961.13 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 1,177.06 | 1,140.18 | 1,064.71 | 343.11 |
| Property, Plant and Equipments | 155.89 | 137.25 | 139.23 | 115.13 |
| Right-of-Use Assets | 180.14 | 173.40 | 109.49 | 103.13 |
| Intangible Assets | 841.03 | 810.02 | 810.21 | 124.84 |
| Market Cap (Rs in Crs) | 8,736.00 | |
|---|---|---|
| P/E | 65.82 | |
| Book Value (Rs) | 215.64 | |
| Div (%) | 200 | |
| Market Lot | 1 | |
| EPS (TTM) | 25.88 | |
|---|---|---|
| Price/Book | 7.90 | |
| Div Yield.(%) | 0.23 | |
| Face value (RS) | 2 | |
| Deliverables (%) | 50.35 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Dr Lal Pathlabs... | 22,806.75 | 2,769.65 | 2,728.35 | 1.51 | 3,645.00 - 2,210.00 |
| Vijaya Diagnost... | 11,292.56 | 1,141.85 | 1,100.25 | 3.78 | 1,276.75 - 653.00 |
| Thyrocare Techn... | 3,872.76 | 742.00 | 730.80 | 1.53 | 1,053.05 - 570.75 |
| Krsnaa Diagnost... | 2,614.83 | 805.00 | 809.80 | -0.59 | 1,041.80 - 527.55 |
| Suraksha Diagno... | 1,618.67 | 312.85 | 310.80 | 0.66 | 449.00 - 233.15 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 86,52,022 | 16.88 |
| Total Institutions | 1,53,80,075 | 30.00 |
| Total Govt Holding | 0 | 0.00 |
| Total Non Promoter Corporate Holding | 1,04,178 | 0.20 |
| Total Promoters | 2,53,27,991 | 49.41 |
| Total Public & others | 1803070 | 3.51 |
| Total | 5,12,67,336 | 100 |
